Conavi Medical Valuation

Is CNVI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CNVI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CNVI's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CNVI's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CNVI?

Key metric: As CNVI is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CNVI. This is calculated by dividing CNVI's market cap by their current revenue.
What is CNVI's PS Ratio?
PS Ratio8.1x
SalesCA$3.64m
Market CapCA$25.22m

Price to Sales Ratio vs Peers

How does CNVI's PS Ratio compare to its peers?

The above table shows the PS ratio for CNVI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average21.1x
NGMD NuGen Medical Devices
27.1xn/aCA$20.7m
ASG Aurora Spine
1.4xn/aCA$32.5m
MDX MedX Health
55.1xn/aCA$18.9m
NSCI Nanalysis Scientific
0.8x6.1%CA$36.2m
CNVI Conavi Medical
8.1xn/aCA$25.2m

Price-To-Sales vs Peers: CNVI is good value based on its Price-To-Sales Ratio (8.1x) compared to the peer average (21.1x).


Price to Sales Ratio vs Industry

How does CNVI's PS Ratio compare vs other companies in the CA Medical Equipment Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
HTL Hamilton Thorne
3.2x9.1%US$246.63m
NSCI Nanalysis Scientific
0.8x6.1%US$25.73m
ASG Aurora Spine
1.4xn/aUS$23.11m
EVMT Evome Medical Technologies
0.2xn/aUS$6.47m
CNVI 8.1xIndustry Avg. 3.5xNo. of Companies8PS020406080100+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CNVI is expensive based on its Price-To-Sales Ratio (8.1x) compared to the North American Medical Equipment industry average (3.5x).


Price to Sales Ratio vs Fair Ratio

What is CNVI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CNVI PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio8.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate CNVI's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies